REMEDY-PILOT: Coronary Sinus Reducer Shows No Significant Improvement in Patients With CMD and ANOCA
In patients with coronary microvascular dysfunction (CMD) and refractory angina with nonobstructive coronary arteries (ANOCA), coronary sinus reducer (CSR) implantation did not significantly improve myocardial perfusion reserve (MPR), patient-reported symptoms or quality of life, according to results from REMEDY-PILOT trial, presented at TCT 2026.
HD-PCI: Higher Dose Heparin Does Not Show Appreciable Benefit Over Lower Dose During PCI
Higher-dose unfractionated heparin (UFH) during PCI did not improve clinical outcomes vs. a lower-dose strategy, according to findings from the HD-PCI trial presented at TCT 2026.
TCT 2026: Treatment Gaps in Cancer-Related MI and Post-PCI Care
Two large studies out of the Republic of Korea presented at TCT 2026 and published in JACC: Asia point to persistent gaps between evidence and real-world cardiovascular care, from the treatment of acute MI in patients with cancer to the use of guideline-recommended antiplatelet strategies after PCI.
NCDR Research Presented at TCT 2026
Several sessions and abstracts at TCT 2026 in San Diego, CA, feature NCDR registry data. Explore the presentations below to learn more about their findings and potential implications for interventional cardiovascular care.
TCT 2026 Science Published in the JACC Journals
As TCT 2026 kicks off Saturday, Oct. 31, in San Diego, key research from the conference will be simultaneously published across the JACC Journals, providing new findings across the spectrum of interventional cardiology.
JACC: Advances Studies Highlight Mobile STEMI Care, AI-Driven CT Imaging
A mobile app for optimizing STEMI care and use of AI to detect aortic valve calcification on routine noncontrast chest CT are among the innovations being discussed and presented at TCT 2026 and simultaneously published in JACC: Advances.
Healthy Diet May Lower Cardiovascular Disease Risk After Cancer
Adherence to a healthy dietary pattern was associated with a significantly reduced risk of cardiovascular disease among cancer survivors, according to results from a cohort study using UK Biobank data, published Oct. 29 in JACC: Advances.
Dyslipidemia Guidelines: What’s New?
This episode is part of ACC’s ongoing initiative on Implementing the 2026 Dyslipidemia Guidelines.
HTI-5 Final Rule Released: ONC Health IT Certification Program, Information Blocking Updates, More
The Office of the National Coordinator for Health IT (ONC) released the Health Data, Technology and Interoperability: ONC Deregulatory Actions to Unleash Prosperity (HTI-5) final rule, building on the HTI-5 proposed rule from December 2025, to streamline the ONC Health IT Certification Program, update information blocking regulations and support AI-enabled FHIR-based interoperability.
2026 International Criteria For ECG Interpretation in Athletes
Electrocardiographic (ECG) interpretation in athletes continues to evolve as clinicians attempt to balance two competing priorities: 1) identifying occult cardiovascular disease; and 2) minimizing false-positive screening results that cause unnecessary downstream testing and sport restriction.
